BioCentury | Sep 29, 2017
Financial News

Engage, Integra raise venture financings

...round led by TPG Biotech, with participation from fellow new investors Adage Capital Management and Lumira Capital...
BioCentury | Sep 28, 2017
Financial News

Venture roundup: Engage, Integra

...round led by TPG Biotech, with participation from fellow new investors Adage Capital Management and Lumira Capital...
BioCentury | May 16, 2016
Financial News

G1 Therapeutics completes venture financing

...IB Investment; Cowen Private Investments; Franklin Templeton; Rock Springs Capital; Eshelman Ventures; Hatteras Venture Partners; Lumira Capital...
BioCentury | May 12, 2016
Financial News

G1 raises $47M in C round

...and Rock Springs Capital also participated, as did existing investors Eshelman Ventures, Hatteras Venture Partners, Lumira Capital...
BioCentury | Jan 11, 2016
Financial News

Zymeworks completes venture financing

...Computational chemistry/biology, Antibodies Date completed: 2016-01-08 Type: Venture financing Raised: $61.5 million Investors: BDC Capital; Lumira Capital...
BioCentury | Jan 9, 2016
Financial News

Zymeworks raises $61.5M, invests in Kairos

...Vancouver, B.C.) raised US$61.5 million in a round co-led by new investors BDC Capital and Lumira Capital...
BioCentury | Jun 15, 2015
Financial News

Celtaxsys Inc. completes venture financing

...Business: Pulmonary, Dermatology Date completed: 2015-06-08 Type: Venture financing Raised: $40 million Investors: Domain Associates; Lumira Capital...
BioCentury | Jun 15, 2015
Finance

Domain finds unmet need in CF

...said the series D proceeds provides runway through 1Q18. Other investors in the round included Lumira Capital...
BioCentury | Jun 9, 2015
Financial News

Celtaxsys raises $40 million series D

...D round led by Domain Associates, which invested through its Fund VIII. Also participating were Lumira Capital...
...Phase II study of CTX-4430 to treat moderately severe acne vulgaris. Domain Associates' Nicole Vitullo, Lumira Capital's...
BioCentury | Apr 6, 2015
Financial News

Thrasos Therapeutics completes venture financing

...2015-03-31 Type: Venture financing Raised: $21 million Investors: BDC Capital; SROne; Fonds de solidarite FTQ; Lumira Capital...
Items per page:
1 - 10 of 36
BioCentury | Sep 29, 2017
Financial News

Engage, Integra raise venture financings

...round led by TPG Biotech, with participation from fellow new investors Adage Capital Management and Lumira Capital...
BioCentury | Sep 28, 2017
Financial News

Venture roundup: Engage, Integra

...round led by TPG Biotech, with participation from fellow new investors Adage Capital Management and Lumira Capital...
BioCentury | May 16, 2016
Financial News

G1 Therapeutics completes venture financing

...IB Investment; Cowen Private Investments; Franklin Templeton; Rock Springs Capital; Eshelman Ventures; Hatteras Venture Partners; Lumira Capital...
BioCentury | May 12, 2016
Financial News

G1 raises $47M in C round

...and Rock Springs Capital also participated, as did existing investors Eshelman Ventures, Hatteras Venture Partners, Lumira Capital...
BioCentury | Jan 11, 2016
Financial News

Zymeworks completes venture financing

...Computational chemistry/biology, Antibodies Date completed: 2016-01-08 Type: Venture financing Raised: $61.5 million Investors: BDC Capital; Lumira Capital...
BioCentury | Jan 9, 2016
Financial News

Zymeworks raises $61.5M, invests in Kairos

...Vancouver, B.C.) raised US$61.5 million in a round co-led by new investors BDC Capital and Lumira Capital...
BioCentury | Jun 15, 2015
Financial News

Celtaxsys Inc. completes venture financing

...Business: Pulmonary, Dermatology Date completed: 2015-06-08 Type: Venture financing Raised: $40 million Investors: Domain Associates; Lumira Capital...
BioCentury | Jun 15, 2015
Finance

Domain finds unmet need in CF

...said the series D proceeds provides runway through 1Q18. Other investors in the round included Lumira Capital...
BioCentury | Jun 9, 2015
Financial News

Celtaxsys raises $40 million series D

...D round led by Domain Associates, which invested through its Fund VIII. Also participating were Lumira Capital...
...Phase II study of CTX-4430 to treat moderately severe acne vulgaris. Domain Associates' Nicole Vitullo, Lumira Capital's...
BioCentury | Apr 6, 2015
Financial News

Thrasos Therapeutics completes venture financing

...2015-03-31 Type: Venture financing Raised: $21 million Investors: BDC Capital; SROne; Fonds de solidarite FTQ; Lumira Capital...
Items per page:
1 - 10 of 36